OOIR: Observatory of International Research

Papers

(The H4-Index of BMC Pulmonary Medicine is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Radiation-induced lung injury: current evidence	124
Chest x-ray findings and temporal lung changes in patients with COVID-19 pneumonia	123
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome	82
SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital	82
Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis	60
Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study	56
COVID-19 related concerns of people with long-term respiratory conditions: a qualitative study	55
The application of metagenomic next-generation sequencing in diagnosing Chlamydia psittaci pneumonia: a report of five cases	53
Ultrasound and non-ultrasound imaging techniques in the assessment of diaphragmatic dysfunction	53
The global impact of Aspergillus infection on COPD	49
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort	48
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysi	43
Correlation between MMP2 expression in lung cancer tissues and clinical parameters: a retrospective clinical analysis	41
Real-life experience with benralizumab during 6 months	40
Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature review	39
Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study	37
Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease	37
Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age–period–cohort analysis	36
CT differential diagnosis of COVID-19 and non-COVID-19 in symptomatic suspects: a practical scoring method	35
Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic	34
Association between tumor necrosis factor alpha and obstructive sleep apnea in adults: a meta-analysis update	33
The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice	32
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study	30
Elevated glucose level leads to rapid COVID-19 progression and high fatality	30
LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP	29

Shape-sensing robotic-assisted bronchoscopy for pulmonary nodules: initial multicenter experience using the Ion™ Endoluminal System	29
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study	28
The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study	28